Skip to content

Plasma Rich in Growth Factors in the Preservation of the Alveolar Ridge After Simple Molar Tooth Extractions.

Randomized Clinical Trial, Controlled by Conventional Treatment, of Plasma Rich in Growth Factors (PRGF®) in the Preservation of the Alveolar Ridge After Simple Molar Tooth Extractions.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04945629
Enrollment
44
Registered
2021-06-30
Start date
2020-09-02
Completion date
2025-01-31
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implantation

Keywords

exodontia, PRGF, Alveolar Ridge preservation

Brief summary

This Randomized Clinical Trial aims to study the efficacy and safety of PRGF-Endoret in alveolar ridge preservation after single molar extractions. The control group is the spontaneous healing occuring after the suturing of the alveolus. The primary endpoint is the bone regeneration measured in biopsies obtained from the regenerated alveolar bone.

Interventions

Filling of the alveolus with PRGF clot and fibrin plug.

DRUGBlood clot and simple suture

Filling the alveolus with blood clot

Sponsors

Fundación Eduardo Anitua
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age\> 18 years * Clinical indication for simple tooth extraction in the posterior sectors (from the second premolar to upper and lower second molars) * Need to place a dental implant in the same position of the extraction * Availability of observation during the period of treatment * Signature of the informed consent

Exclusion criteria

* Third molars * Active periodontal disease * Simultaneous extraction of two adjacent pieces in the same quadrant * Oral dehiscence ≥ 25% * Alveolus depth \<7mm * Loss of some wall of the alveolus * Severe inflammation in the extraction area * Previous diagnosis of coagulopathies * Previous diagnosis of autoimmune disease * Be receiving, or have received the 30 days prior to extraction treatment with radiotherapy, chemotherapy, immunosuppressants, systemic corticosteroids or anticoagulants * Regular treatment with NSAIDs * History of chronic hepatitis or liver cirrhosis * Positive markers for HCV, AfHBs, HIV-I / II or TP * Diabetes mellitus with poor metabolic control (evidence of glycated hemoglobin\> 9%) * Dialysis treatment * Presence of malignant tumors, hemangiomas or angioma in the extraction area. * History of ischemic heart disease in the last year * Pregnancy or women of childbearing age who do not take action contraceptives * Lactating women * Previous diagnosis of metabolic bone disease * Antiresorptive treatment * Treatment with monoclonal antibodies * Smoker\> 10 cigarettes / day * Any inability to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Bone regeneration12 weeks post-extractionQuantity of new bone measured in bone biopsies obtained after alveolar ridge preservation

Secondary

MeasureTime frameDescription
Inflammation score3, 7 and 15 days post-extractionEvolution of inflammation evaluated by ordinal scale from 0 to 3 (0=no inflammation; 3=severe inflammation)
Soft tissue healing index3, 7 and 15 days post-extractionSoft tissue healing index according to the scale of Laundry. Values ranging 1 to 5 (1=poor healing, 5=excellent healing)
Changes in the dimension of the alveolar ridge12 weeks post-extractionChanges in the dimension of the alveolar ridge by means of superimposition of digital files of models of plaster after 12 weeks post-extraction
Soft tissue histomorphometric changes12 weeks post-extraction\- Soft tissue histomorphometric changes after evaluated by soft tissue biopsy
Visual Analogue Score (VAS)3, 7 and 15 days post-extractionEvolution of pain assessed by the visual analog scale (VAS). Values ranging 0 to 10 (0=no pain and 10=worst pain)
Change in bone density12 weeks post-extractionChange in bone density (Hounsfield units) evaluated by the CBCT at three different points between the post-extraction week and 12 weeks.
Vitamin D levels12 weeks post-extraction
Frequency of surgical and postsurgical complications12 weeks post-extraction
Change in the bone dimensions of the alveolar ridge12 weeks post-extractionChange in the bone dimensions of the alveolar ridge evaluated by CBCT between the post-extraction day and the week 12 post-extraction.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026